Skip to main content

CDNA CareDx, Inc

Healthcare

87.41 +15.89 +22.22% Close 10/30
Since 2024-11-29 +191.4%
Open
80.61
High
90.87
Low
80.44
Prev close
71.52
Volume
3.6M
Amplitude
14.58%
P/E
29.9
P/B
8.0
Revenue YoY (TTM)
+38.9%
52W 14.27 90.87

Is CareDx, Inc a buy? Fundamentals and valuation first

As of 2026-10-29

Quality: Good, Growth: Strong, Momentum: Strong, Risk / liquidity: Good; Valuation: Pricey.

Valuation Pricey Free-cash-flow yield is Good, but Price / book is Expensive.
TTM P/E 29.92 68th percentile Pricey
Price / book 8.04 90th percentile Expensive
Free-cash-flow yield (%) 1.6 53th percentile Good
US Stock Backtest in Python: Price-to-Book Ratio StrategyQuality Factor Investing: A US Quality Value Backtest
Quality Good ROE, TTM is Top, but Operating margin, TTM is Average.
ROE, TTM (%) 27.52 87th percentile Top
Operating margin, TTM (%) 0.86 38th percentile Average
FCF margin, TTM (%) 12.08 65th percentile Good
Quality Factor Investing: A US Quality Value Backtest
Growth Strong All 2 indicators are Top.
Revenue growth, TTM YoY (%) 38.94 85th percentile Top
Diluted EPS growth, TTM YoY (%) 100.64 84th percentile Top
Momentum Strong All 2 indicators are Top.
60-day return (%) 57.19 98th percentile Top
240-day return (%) 350.66 100th percentile Top
Momentum Trading Strategy: A 12-1 Momentum Backtest
Risk / liquidity Good 20-day dollar volume is Top, but 60-day annualized volatility is Average.
20-day dollar volume 88,572,245 86th percentile Top
60-day annualized volatility (%) 49 54th percentile Average
Factor Investing Explained: 10 Classic Factors in US Stocks

CareDx, Inc (CDNA) today

4 quant signals active · As of 2026-10-29

Win rate and excess are historical post-trigger stats vs the market. Click a signal for its full definition and samples; history does not predict future results.

FinLab Studio

From CareDx, Inc to every stock like it

AI finds several complementary traits of CareDx, Inc across different dimensions, combines them into a multifactor strategy, and backtests it against the market.

Screen stocks like CareDx, Inc

CareDx, Inc (CDNA) peers and tracking

Watchlist

This page refreshes daily after the close. Add CareDx, Inc to your watchlist to track signal changes on your next visit.

CareDx, Inc (CDNA) quant signal backtests

Signals active now

Each active condition is tested against this stock’s own history and benchmarked versus the S&P 500.

52-week adjusted-price high

Active

Adjusted close first reaches a 252-trading-day high; repeated hits within 20 days count once.

17 historical occurrences (since 2017-09-26)

Average forward return after 52-week adjusted-price high

20-day: Win 68.8%, Sample 16, Median +15.85%, Excess +13.87%, Beat mkt rate 62.5%

60-day: Win 80%, Sample 15, Median +56.5%, Excess +43.92%, Beat mkt rate 80%

120-day: Win 76.9%, Sample 13, Median +46.1%, Excess +46.03%, Beat mkt rate 76.9%

120 days after: historical avg +55.04%

20-day +15.07%
60-day +47.43%
120-day +55.04%
20-day
60-day
120-day
Win
68.8%
80%
76.9%
Sample
16
15
13
Median
+15.85%
+56.5%
+46.1%
Excess
+13.87%
+43.92%
+46.03%
Beat mkt rate
62.5%
80%
76.9%

Over 13 occurrences, 120-day forward avg gained 55.04%, beat the market by 46.03 pts; win rate 76.9%.

Top-quintile 6-month momentum

Active · now 99.83%

The stock ranks in the top 20% of the liquid US common-stock universe by 126-day adjusted return.

Momentum Trading Strategy: A 12-1 Momentum Backtest
16 historical occurrences (since 2017-08-24)

Average forward return after Top-quintile 6-month momentum

20-day: Win 56.2%, Sample 16, Median +5.53%, Excess +3.94%, Beat mkt rate 50%

60-day: Win 68.8%, Sample 16, Median +20.92%, Excess +32.81%, Beat mkt rate 62.5%

120-day: Win 73.3%, Sample 15, Median +69.01%, Excess +55.82%, Beat mkt rate 73.3%

120 days after: historical avg +68.39%

20-day +5.35%
60-day +38.91%
120-day +68.39%
20-day
60-day
120-day
Win
56.2%
68.8%
73.3%
Sample
16
16
15
Median
+5.53%
+20.92%
+69.01%
Excess
+3.94%
+32.81%
+55.82%
Beat mkt rate
50%
62.5%
73.3%

Over 15 occurrences, 120-day forward avg gained 68.39%, beat the market by 55.82 pts; win rate 73.3%.

Filed revenue acceleration

Active · now 38.94%

TTM revenue growth is at least 10% and improved versus the prior filed quarter; event date is the SEC filing date.

14 historical occurrences (since 2018-08-09)

Average forward return after Filed revenue acceleration

20-day: Win 53.8%, Sample 13, Median +1.14%, Excess +4.16%, Beat mkt rate 53.8%

60-day: Win 53.8%, Sample 13, Median +2.33%, Excess +13.13%, Beat mkt rate 53.8%

120-day: Win 33.3%, Sample 12, Median -7.98%, Excess +3.92%, Beat mkt rate 33.3%

120 days after: historical avg +13.05%

20-day +5.39%
60-day +16.47%
120-day +13.05%
20-day
60-day
120-day
Win
53.8%
53.8%
33.3%
Sample
13
13
12
Median
+1.14%
+2.33%
-7.98%
Excess
+4.16%
+13.13%
+3.92%
Beat mkt rate
53.8%
53.8%
33.3%

Over 12 occurrences, 120-day forward avg gained 13.05%, beat the market by 3.92 pts; win rate 33.3%.

EPS surprise beat

Active · now 174.73%

Reported EPS beat consensus estimate by at least 5%; event date is the earnings-surprise timestamp.

PEAD: Post-Earnings Announcement Drift Backtest
31 historical occurrences (since 2015-03-17)

Average forward return after EPS surprise beat

20-day: Win 65.5%, Sample 29, Median +8%, Excess +11.08%, Beat mkt rate 58.6%

60-day: Win 69%, Sample 29, Median +14.84%, Excess +31.05%, Beat mkt rate 65.5%

120-day: Win 53.6%, Sample 28, Median +30.23%, Excess +62.41%, Beat mkt rate 57.1%

120 days after: historical avg +71.15%

20-day +13.02%
60-day +34.94%
120-day +71.15%
20-day
60-day
120-day
Win
65.5%
69%
53.6%
Sample
29
29
28
Median
+8%
+14.84%
+30.23%
Excess
+11.08%
+31.05%
+62.41%
Beat mkt rate
58.6%
65.5%
57.1%

Over 28 occurrences, 120-day forward avg gained 71.15%, beat the market by 62.41 pts; win rate 53.6%.

More history: Market-wide momentum baseline

Market-wide momentum baseline

Across 99,554 liquid US common-stock samples, top-quintile 6-month momentum was followed by an average 60-trading-day return of +6.46%, a 58.5% positive-return rate, and +3.11 percentage points of average excess return versus the S&P 500.

Baseline: weekly samples since 2016 where a liquid US common stock ranked in the top quintile by 126-trading-day momentum. Forward return is 60 trading days; excess return is versus S&P 500 (^GSPC).

Method and limits

  • Returns use us_price:adj_close, adjusted for splits and dividends where available.
  • Excess returns use world_index:^GSPC as the S&P 500 benchmark proxy.
  • Quarterly fundamentals are aligned to SEC filing dates before daily valuation studies.
  • The promoted universe starts from active NYSE/NASDAQ common stocks, then applies price and dollar-volume gates.
  • Snapshot-only tables such as analyst consensus, DCF, us_ratios, and us_key_metrics are intentionally excluded from historical evidence.
  • Overlapping event windows are descriptive distributions, not independent samples.

This page is for historical data analysis and education only. It is not investment advice. Backtests and historical return distributions do not predict future performance; evaluate risk independently before trading.